About Anula Jayasuriya
Form D filings for Aarvik Therapeutics from 2021 to 2024 list Anula Jayasuriya as director.
Anula Jayasuriya first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Anula Jayasuriya in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anula Jayasuriya works with at each company, as listed on that company's latest Form D.
Aarvik Therapeutics, Inc. · Form D, Dec 11, 2024
SS
Sachdev Sidhu
Director
JJ
Jagath Reddy Junutula
Chief Executive Officer and director
RR
Ram Reddy
Director
RS
Richard Scheller
Director